Tag: <span>recall</span>

Home / recall
Post

PICATO (ingenol mebutate gel, 0.015% and 0.05%) – Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer

At Health Canada’s request, LEO Pharma Inc. is withdrawing Picato from the Canadian market. This follows a safety review by the Department, which concluded that use of Picato may be associated with an increased risk of non-melanoma skin cancer, and that the benefits of using Picato no longer outweigh its potential risks. HMC

Post

Recall of certain hand sanitizers that contain technical-grade ethanol

Health Canada is advising Canadians that certain lots of the following hand sanitizer are being recalled from the market because they contain ethanol or denaturants that are not acceptable for use in hand sanitizers in Canada. Product Unacceptable Ingredient Recalling Company NPN or DIN Lot numbers Expiry Date Date Added Clean & Green Hand Sanitizer...

Post

Certain Metformin diabetes drugs recalled due to the presence of NDMA

Ranbaxy Pharmaceuticals Canada Inc. is recalling six lots of its prescription RAN-Metformin drug from the Canadian market. Company testing identified two lots (#AJY8006A and #AJY8007A) with levels of NDMA above what is considered acceptable if the drug were to be taken over a lifetime. The company is recalling an additional four lots (#AJY8005A, #AJY8005B, #AJY8008A...

Post

Several children’s strawberry-flavoured acetaminophen syrups recalled.

Several children’s strawberry-flavoured acetaminophen syrups recalled because of defective child-resistant safety caps on the bottles.  November 2018 The recall has been expanded to include all lots of children’s strawberry-flavoured acetaminophen syrups labeled as Biomedic, Option+, or Laboratoires Trianon Inc. because of defective child-resistant safety caps. HMC

Post

Several drugs containing valsartan being recalled due to contamination with a potential carcinogen

Several drugs containing the ingredient valsartan are being recalled by their manufacturers. An impurity, N-nitrosodimethylamine (NDMA), was found in the valsartan used in these products. NDMA is a potential human carcinogen, which means that it could cause cancer with long-term exposure. See your physician or pharmacist right away if you are taking this blood pressure...